• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中突触功能障碍的机制。

Mechanisms of synaptic dysfunction in Alzheimer's disease.

作者信息

Masliah E

机构信息

Department of Neurosciences, University of California, San Diego, La Jolla 92093-0624, USA.

出版信息

Histol Histopathol. 1995 Apr;10(2):509-19.

PMID:7599445
Abstract

Alzheimer's disease (AD) is characterized by a progressive cognitive decline in which memory, initiation, learning and conceptualization are severely affected. The main histopathological alterations are the presence of amyloid beta/A4-containing plaques, tangles and amyloid angiopathy. It is believed that these brain alterations are associated with abnormal expression and/or processing of amyloid precursor protein (APP) and with abnormal assembly of cytoskeletal proteins. Recent quantitative studies with the electron microscope and with immunochemical/immunocytochemical assays, using molecular markers for synaptic proteins, have shown that synaptic loss in the cortex is the major correlate of the patterns of cognitive decline in AD. The synaptic loss in AD is accompanied by neuronal loss and aberrant sprouting, and studies in incipient AD cases have shown that this alteration occurs very early in the progression of the disease preceding tangle formation and neuronal loss. These results suggest that damage to the synaptic terminal plays a central role in the pathogenesis of AD. The mechanisms of synaptic pathology in AD are not yet clear, however, studies in transgenic animal models support the possibility that APP participates in synaptic stabilization and that abnormal metabolism of this molecule could lead to synaptic dysfunction which, in turn, results in neurodegeneration and dementia.

摘要

阿尔茨海默病(AD)的特征是进行性认知衰退,其中记忆、启动能力、学习和概念化能力受到严重影响。主要的组织病理学改变是含有β-淀粉样蛋白/A4的斑块、缠结和淀粉样血管病。据信,这些脑部改变与淀粉样前体蛋白(APP)的异常表达和/或加工以及细胞骨架蛋白的异常组装有关。最近使用突触蛋白分子标记物的电子显微镜以及免疫化学/免疫细胞化学分析的定量研究表明,皮质中的突触丧失是AD认知衰退模式的主要相关因素。AD中的突触丧失伴随着神经元丧失和异常出芽,对早期AD病例的研究表明,这种改变在疾病进展中非常早地发生,早于缠结形成和神经元丧失。这些结果表明,突触终末损伤在AD发病机制中起核心作用。然而,AD中突触病理学的机制尚不清楚,转基因动物模型的研究支持APP参与突触稳定的可能性,并且该分子的异常代谢可能导致突触功能障碍,进而导致神经退行性变和痴呆。

相似文献

1
Mechanisms of synaptic dysfunction in Alzheimer's disease.阿尔茨海默病中突触功能障碍的机制。
Histol Histopathol. 1995 Apr;10(2):509-19.
2
[Advances in molecular pathology of Alzheimer's disease].[阿尔茨海默病分子病理学进展]
Rev Neurol. 2006;42(5):306-9.
3
Alzheimer's disease pathogenesis and therapeutic interventions.阿尔茨海默病的发病机制与治疗干预措施。
J Clin Neurosci. 2004 Jun;11(5):456-67. doi: 10.1016/j.jocn.2003.12.007.
4
Amyloid flirting with synaptic failure: towards a comprehensive view of Alzheimer's disease pathogenesis.淀粉样蛋白与突触功能障碍的关联:迈向对阿尔茨海默病发病机制的全面认识
Eur J Pharmacol. 2008 May 6;585(1):109-18. doi: 10.1016/j.ejphar.2007.11.083. Epub 2008 Mar 4.
5
Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.携带弥漫性β淀粉样蛋白沉积但不形成斑块的β淀粉样前体蛋白转基因小鼠表现出缺血易损性增加:炎症的作用。
Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1610-5. doi: 10.1073/pnas.032670899. Epub 2002 Jan 29.
6
Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.APP/PS1小鼠中与年龄相关的阿尔茨海默样病理的渐进性发展。
Ann Neurol. 2004 Jun;55(6):801-14. doi: 10.1002/ana.20101.
7
[Studying pathogenesis of Alzheimer's disease in a Drosophila melanogaster model: human APP overexpression in the brain of transgenic flies leads to deficit of the synaptic protein synaptotagmin].[在果蝇模型中研究阿尔茨海默病的发病机制:转基因果蝇大脑中人类淀粉样前体蛋白(APP)的过表达导致突触蛋白突触结合蛋白缺乏]
Genetika. 2009 Jan;45(1):119-26.
8
Synaptic degeneration in Alzheimer's disease.阿尔茨海默病中的突触退化
Acta Neuropathol. 2009 Jul;118(1):167-79. doi: 10.1007/s00401-009-0536-x. Epub 2009 Apr 24.
9
Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.β-淀粉样蛋白对突触可塑性的破坏:潜在的阿尔茨海默病改善疗法的调节作用
Biochem Soc Trans. 2005 Aug;33(Pt 4):563-7. doi: 10.1042/BST0330563.
10
[Alzheimer's disease: lesions and their progression].[阿尔茨海默病:病变及其进展]
Rev Neurol (Paris). 1999;155 Suppl 4:S17-27.

引用本文的文献

1
Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer's disease.多分析物蛋白质组学分析鉴定出临床前阿尔茨海默病患者血液中的神经炎症、脑血管和突触生物标志物。
Mol Neurodegener. 2024 Oct 10;19(1):68. doi: 10.1186/s13024-024-00753-5.
2
Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer's disease.多分析物蛋白质组学分析可识别临床前阿尔茨海默病中基于血液的神经炎症、脑血管和突触生物标志物。
medRxiv. 2024 Jun 16:2024.06.15.24308975. doi: 10.1101/2024.06.15.24308975.
3
Isoform-specific effects of neuronal inhibition of AMPK catalytic subunit on LTD impairments in a mouse model of Alzheimer's disease.
阿尔茨海默病小鼠模型中神经元抑制 AMPK 催化亚基对 LTD 损伤的同工型特异性作用。
Neurobiol Aging. 2024 Aug;140:116-121. doi: 10.1016/j.neurobiolaging.2024.05.009. Epub 2024 May 15.
4
Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach.重新排列淀粉样β和 Tau 病理之间的谜题:以 APP 为中心的方法。
Int J Mol Sci. 2023 Dec 23;25(1):259. doi: 10.3390/ijms25010259.
5
Discoveries and future significance of research into amyloid-beta/α7-containing nicotinic acetylcholine receptor (nAChR) interactions.发现并探讨淀粉样β/α7 包含型烟碱型乙酰胆碱受体(nAChR)相互作用的未来意义。
Pharmacol Res. 2023 May;191:106743. doi: 10.1016/j.phrs.2023.106743. Epub 2023 Apr 20.
6
Emerging Roles of Extracellular Vesicles in Alzheimer's Disease: Focus on Synaptic Dysfunction and Vesicle-Neuron Interaction.细胞外囊泡在阿尔茨海默病中的新兴作用:聚焦于突触功能障碍和囊泡-神经元相互作用。
Cells. 2022 Dec 23;12(1):63. doi: 10.3390/cells12010063.
7
Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene dose.唐氏综合征合并阿尔茨海默病患者及 Dp16 小鼠唐氏综合征模型中突触蛋白和 SNARE 复合物减少:APP 基因剂量的影响。
Alzheimers Dement. 2023 May;19(5):2095-2116. doi: 10.1002/alz.12835. Epub 2022 Nov 12.
8
Dysregulation of Neuropeptide and Tau Peptide Signatures in Human Alzheimer's Disease Brain.人类阿尔茨海默病脑中神经肽和 Tau 肽特征的失调。
ACS Chem Neurosci. 2022 Jul 6;13(13):1992-2005. doi: 10.1021/acschemneuro.2c00222. Epub 2022 Jun 27.
9
Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer's disease.小胶质细胞的大细胞外囊泡在阿尔茨海默病中促进早期突触功能障碍。
Brain. 2022 Aug 27;145(8):2849-2868. doi: 10.1093/brain/awac083.
10
Planar cell polarity signaling components are a direct target of β-amyloid-associated degeneration of glutamatergic synapses.平面细胞极性信号成分是谷氨酸能突触与β-淀粉样体相关退化的直接靶点。
Sci Adv. 2021 Aug 18;7(34). doi: 10.1126/sciadv.abh2307. Print 2021 Aug.